234 related articles for article (PubMed ID: 9881776)
21. Anti-HIV-1 activity and structure-activity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope.
Lian W; Wu M; Huang N; Gao N; Xiao C; Li Z; Zhang Z; Zheng Y; Peng W; Zhao J
Biochim Biophys Acta; 2013 Oct; 1830(10):4681-91. PubMed ID: 23769857
[TBL] [Abstract][Full Text] [Related]
22. Directed polyvalent display of sulfated ligands on virus nanoparticles elicits heparin-like anticoagulant activity.
Mead G; Hiley M; Ng T; Fihn C; Hong K; Groner M; Miner W; Drugan D; Hollingsworth W; Udit AK
Bioconjug Chem; 2014 Aug; 25(8):1444-52. PubMed ID: 24960223
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of sulfated oligosaccharide glycosides having high anti-HIV activity and the relationship between activity and chemical structure.
Katsuraya K; Nakashima H; Yamamoto N; Uryu T
Carbohydr Res; 1999 Feb; 315(3-4):234-42. PubMed ID: 10399296
[TBL] [Abstract][Full Text] [Related]
24. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy.
Baba M; Schols D; Pauwels R; Nakashima H; De Clercq E
J Acquir Immune Defic Syndr (1988); 1990; 3(5):493-9. PubMed ID: 1691288
[TBL] [Abstract][Full Text] [Related]
25. A heparin-like glycosaminoglycan from shrimp containing high levels of 3-O-sulfated D-glucosamine groups in an unusual trisaccharide sequence.
Chavante SF; Brito AS; Lima M; Yates E; Nader H; Guerrini M; Torri G; Bisio A
Carbohydr Res; 2014 May; 390():59-66. PubMed ID: 24708994
[TBL] [Abstract][Full Text] [Related]
26. Sulfated alkyl oligosaccharides with potent inhibitory effects on human immunodeficiency virus infection.
Uryu T; Ikushima N; Katsuraya K; Shoji T; Takahashi N; Yoshida T; Kanno K; Murakami T; Nakashima H; Yamamoto N
Biochem Pharmacol; 1992 Jun; 43(11):2385-92. PubMed ID: 1351727
[TBL] [Abstract][Full Text] [Related]
27. Elucidation of anti-HIV mechanism of sulfated cellobiose-polylysine dendrimers.
Weiyue S; Ying L; Kanamoto T; Asai D; Takemura H; Nakashima H; Miyazaki K; Yoshida T
Carbohydr Res; 2020 Sep; 495():108084. PubMed ID: 32658833
[TBL] [Abstract][Full Text] [Related]
28. Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides.
Watson K; Gooderham NJ; Davies DS; Edwards RJ
Biochem Pharmacol; 1999 Apr; 57(7):775-83. PubMed ID: 10075083
[TBL] [Abstract][Full Text] [Related]
29. Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1.
Pearce-Pratt R; Phillips DM
Biol Reprod; 1996 Jan; 54(1):173-82. PubMed ID: 8838015
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human immunodeficiency virus infection by heparin derivatives.
Clayette P; Moczar E; Mabondzo A; Martin M; Toutain B; Marcé D; Dormont D
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):63-9. PubMed ID: 8825620
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
32. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides.
Artan M; Karadeniz F; Karagozlu MZ; Kim MM; Kim SK
Carbohydr Res; 2010 Mar; 345(5):656-62. PubMed ID: 20117763
[TBL] [Abstract][Full Text] [Related]
33. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities.
Liu H; Geng M; Xin X; Li F; Zhang Z; Li J; Ding J
Glycobiology; 2005 May; 15(5):501-10. PubMed ID: 15616125
[TBL] [Abstract][Full Text] [Related]
34. Effect of Xylan Sulfates on Coagulation of Human Blood Plasma.
Drozd NN; Kuznetsova SA; Levdansky VA; Mikhailenko MA
Bull Exp Biol Med; 2017 Dec; 164(2):158-161. PubMed ID: 29185171
[TBL] [Abstract][Full Text] [Related]
35. Sulfation and biological activities of konjac glucomannan.
Bo S; Muschin T; Kanamoto T; Nakashima H; Yoshida T
Carbohydr Polym; 2013 May; 94(2):899-903. PubMed ID: 23544648
[TBL] [Abstract][Full Text] [Related]
36. Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity.
Baba M; De Clercq E; Schols D; Pauwels R; Snoeck R; Van Boeckel C; Van Dedem G; Kraaijeveld N; Hobbelen P; Ottenheijm H
J Infect Dis; 1990 Feb; 161(2):208-13. PubMed ID: 2405068
[TBL] [Abstract][Full Text] [Related]
37. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
38. Preparation, characterization and in vitro anticoagulant activity of corn stover xylan sulfates.
Cheng HL; Liu H; Feng QH; Xie YM; Zhan HY
J Biomater Sci Polym Ed; 2017 Feb; 28(3):271-283. PubMed ID: 27931163
[TBL] [Abstract][Full Text] [Related]
39. Heparin-like properties of sulfated alginates with defined sequences and sulfation degrees.
Arlov Ø; Aachmann FL; Sundan A; Espevik T; Skjåk-Bræk G
Biomacromolecules; 2014 Jul; 15(7):2744-50. PubMed ID: 24844124
[TBL] [Abstract][Full Text] [Related]
40. Isolation and anticoagulant properties of a new sulfated xylan: comparison with heparin and a sodium pentosan polysulfate (SP-54).
Doctor VM; Sauls V
Thromb Res; 1983 Jun; 30(6):573-8. PubMed ID: 6193601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
